Andrew Chang
Novo Nordisk, United States
Vice President, Quality and Regulatory Compliance
Dr. Andrew Chang is a multifaceted quality and CMC leader with 28 years well-rounded medical product regulatory and industry experiences. He is a board director for CASSS-Sharing Science Solutions and PDA, respectively. Andrew has served as a member of the planning committee for DIA global annual conferences from 2019 to 2023. At his current capacity as a VP, Quality and Regulatory Compliance, Global Regulatory Affairs, Novo Nordisk, Inc., he provides strategic leadership on Regulatory and Quality related Policy, External Affairs, strategic advice and solutions to quality and regulatory related challenges. Prior to industry, Andrew served more than 11 years in US FDA most recently as an Associate Director for Policy and Regulation, DH/CBER
or sign up with email →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
